SELECTIVE BRAIN TO BLOOD EFFLUX TRANSPORT OF PARA-AMINOHIPPURIC ACID ACROSS THE BLOOD-BRAIN-BARRIER - IN-VIVO EVIDENCE BY USE OF THE BRAIN EFFLUX INDEX METHOD
A. Kakee et al., SELECTIVE BRAIN TO BLOOD EFFLUX TRANSPORT OF PARA-AMINOHIPPURIC ACID ACROSS THE BLOOD-BRAIN-BARRIER - IN-VIVO EVIDENCE BY USE OF THE BRAIN EFFLUX INDEX METHOD, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1018-1025
Efflux transport of para-aminahippuric acid (PAH) across the blood-bra
in barrier (BBB) has been demonstrated by use of the brain efflux inde
x (BEI) method. PAH was eliminated from the ipsilateral cerebrum exten
sively with an apparent efflux rate constant of 0.0587 (min(-1)) after
microinjection into a cerebral cortex region termed Par2. This efflux
transport showed a saturation with the Michaelis constant of approxim
ately 400 mu M. No more than 3% dose of PAH and carboxyl-inulin, used
as a reference compound showing limited permeability at the BBB, were
found in the contralateral cerebrum, cerebellum or cerebrospinal fluid
up to 20 min after administration, Under saturated conditions for car
rier-mediated efflux of PAH via the blood-cerebrospinal fluid barrier,
the BEI Value of PAH did not change significantly which suggested tha
t blood-cerebrospinal fluid barrier was not responsible for the elimin
ation of PAH from the brain after microinjection. No significant metab
olism of PAH was demonstrated in the brain for at least 20 min after m
icroinjection, and most of the radioactivity in the ipsilateral and co
ntralateral carotid veins was as the intact form. With the distributio
n volume of PAH, 0.800 ml/g brain, obtained from the brain slice uptak
e experiment, the apparent efflux clearance was calculated as 46.9 mu
l/min/g brain. In addition, the influx clearance of PAH across the BBB
determined by the in vivo brain uptake index method was much smaller
than the efflux clearance, which demonstrates that BBB transports PAH
selectively from the brain to the circulating blood.